Vanguard Group Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,804,092 shares of RVPH stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,804,092
Previous 1,804,092
-0.0%
Holding current value
$1.52 Million
Previous $1.71 Million
60.01%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
14.5MCall Options Held
4.9MPut Options Held
29.7K-
Diadema Partners LP Morristown, NJ2.74MShares$2.3 Million0.32% of portfolio
-
Armistice Capital, LLC New York, NY2.69MShares$2.26 Million0.02% of portfolio
-
Heights Capital Management, Inc San Francisco, CA1.83MShares$1.54 Million0.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.49MShares$1.25 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1MShares$840,0000.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $17.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...